Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Running, not enrolling

Conditions studied: COVID-19 Infection, Malignant Solid Neoplasm

In brief

This study uses questionnaires to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted health-related quality of life (HRQOL) and other areas such as COVID-19-specific psychological distress, disruptions to health care, finances and social interactions in cancer patients. The coronavirus disease 2019 (COVID-19) is an infectious disease that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The information learned from this study will guide the development of psychosocial programs to improve patient care and outcomes in cancer patients and survivors in the context of facing a global pandemic.

Key facts

Study ID

NCT04447222

Run by

M.D. Anderson Cancer Center

People needed

1242

Starts

2020-05-12

Expected to finish

2026-07-30

Last updated by the study team

2026-02-19

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Prior patients who participated in one of the following protocols: 2012-0112, 2009-0976, or 2005-0035
• Has an active email address or can be contacted via MyChart or personal email

You may not qualify if…

• No evidence of consent from prior clinical trials

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.